Physiological, pathological and potential therapeutic roles of adipokines

Drug Discovery Today

Volumn 17, Issue 15-16, 2012, Pages 880-889

  Falcão Pires, Inês ^a   Castro Chaves, Paulo ^a   Miranda Silva, Daniela ^a   Lourenço, André P ^a   Leite Moreira, Adelino F ^a  

^a University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; ADIPONECTIN; APELIN; FATTY ACID BINDING PROTEIN; GLITAZONE DERIVATIVE; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRAMLINTIDE; RESISTIN; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULINEMIA; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CYTOKINES; HUMANS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84864628574     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.04.007     Document Type: Review

References (162)

1. P.K. Siiteri Adipose tissue as a source of hormones Am. J. Clin. Nutr. 45 1987 277 282
2. Y. Zhang Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432 (Pubitemid 24365442)
3. S.P. Weisberg Obesity is associated with macrophage accumulation in adipose tissue J. Clin. Invest. 112 2003 1796 1808 (Pubitemid 38063703)
4. A. Divoux Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss Diabetes 59 2010 2817 2825
5. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J. Clin. Endocrinol. Metab. 89 2004 2548 2556 (Pubitemid 38766330)
6. A. Rodriguez Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr. Pharm. Des. 13 2007 2169 2175 (Pubitemid 47074048)
7. E.D. Rosen, and B.M. Spiegelman Adipocytes as regulators of energy balance and glucose homeostasis Nature 444 2006 847 853 (Pubitemid 46024991)
8. T.R.A.F. Sam Adiponectin in cardiovascular inflammation and obesity Int. J. Inflamm. 2011 2011
9. S.H. Han Adiponectin and cardiovascular disease: response to therapeutic interventions J. Am. Coll. Cardiol. 49 2007 531 538 (Pubitemid 46177440)
10. D. Kosel Dimerization of adiponectin receptor 1 is inhibited by adiponectin J. Cell Sci. 123 2010 1320 1328
11. M. Nishida Pathophysiological significance of adiponectin Med. Mol. Morphol. 40 2007 55 67 (Pubitemid 47305235)
12. R. Shibata Adiponectin and cardiovascular disease Circ. J. 73 2009 608 614
13. K. Brochu-Gaudreau Adiponectin action from head to toe Endocrine 37 2010 11 32
14. K. Ohashi Adiponectin and hypertension Am. J. Hypertens. 24 2011 263 269
15. Y. Matsuzawa Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease Atheroscler. Suppl. 6 2005 7 14
16. M. Maynadier Adiponectin normalization: a clue to the anti-metabolic syndrome action of rimonabant Drug Discov. Today 14 2009 192 197
17. T. Kadowaki Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J. Clin. Invest. 116 2006 1784 1792 (Pubitemid 44033298)
18. R. Shibata Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat. Med. 11 2005 1096 1103 (Pubitemid 41486832)
19. N. Ouchi, and K. Walsh Adiponectin as an anti-inflammatory factor Clin. Chim. Acta 380 2007 24 30 (Pubitemid 46498041)
20. T.A. Hopkins Adiponectin actions in the cardiovascular system Cardiovasc. Res. 74 2007 11 18 (Pubitemid 46366942)
21. S. Devaraj Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop Arterioscler. Thromb. Vasc. Biol. 28 2008 1368 1374
22. L. Tao Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress Circulation 115 2007 1408 1416 (Pubitemid 46648376)
23. L.Y. Lin Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90 FEBS Lett. 574 2004 106 110
24. C.J. Lavie Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J. Am. Coll. Cardiol. 53 2009 1925 1932
25. F. Sam Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure Endocrinology 151 2010 322 331
26. A. Rodriguez Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats Life Sci. 83 2008 540 549
27. V.W. Dolinsky Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat Hypertension 56 2010 412 421
28. S. Pilz Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study Clin. Chim. Acta 364 2006 251 255 (Pubitemid 43120651)
29. K. Shimada Adiponectin and atherosclerotic disease Clin. Chim. Acta 344 2004 1 12 (Pubitemid 38626132)
30. S. Pilz Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin J. Clin. Endocrinol. Metab. 90 2005 4792 4796 (Pubitemid 41159373)
31. H. Mangge Inflammation, adiponectin, obesity and cardiovascular risk Curr. Med. Chem. 17 2010 4511 4520
32. N. Ouchi Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063 (Pubitemid 32200177)
33. N. Ouchi Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476 (Pubitemid 30005109)
34. N. Ouchi Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
35. N. Kubota Disruption of adiponectin causes insulin resistance and neointimal formation J. Biol. Chem. 277 2002 25863 25866 (Pubitemid 34967064)
36. H. Mangge Preatherosclerosis and adiponectin subfractions in obese adolescents Obesity (Silver Spring) 16 2008 2578 2584
37. H. Mangge Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles Atherosclerosis 203 2009 277 283
38. Kotosai, K. et al. (2011) Adiponectin for treating pulmonary disease. USP20110218146
39. Hess, G. et al. (2011) Predicting cardiovascular events and renal failure in type 1 diabetics. USP20110207629
40. J.J. Maguire [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease Hypertension 54 2009 598 604
41. K. Tatemoto Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochem. Biophys. Res. Commun. 251 1998 471 476 (Pubitemid 28505047)
42. S.L. Pitkin International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function Pharmacol. Rev. 62 2010 331 342
43. H. Chen Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice Peptides 32 2011 1634 1639
44. J. Boucher Apelin, a newly identified adipokine up-regulated by insulin and obesity Endocrinology 146 2005 1764 1771 (Pubitemid 40396885)
45. J. Ishida Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo J. Biol. Chem. 279 2004 26274 26279 (Pubitemid 38798776)
46. A. Salcedo Apelin effects in human splanchnic arteries. Role of nitric oxide and prostanoids Regul. Pept. 144 2007 50 55 (Pubitemid 350030302)
47. S.C. Sorli Therapeutic potential of interfering with apelin signalling Drug Discov. Today 11 2006 1100 1106 (Pubitemid 44792480)
48. I. Falcao-Pires The apelinergic system: a promising therapeutic target Expert Opin. Ther. Targets 14 2010 633 645
49. O. Kunduzova Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes FASEB J. 22 2008 4146 4153
50. S. Rayalam A putative role for apelin in the etiology of obesity Biochem. Biophys. Res. Commun. 368 2008 815 819
51. C. Dray Apelin stimulates glucose utilization in normal and obese insulin-resistant mice Cell Metab. 8 2008 437 445
52. K. Higuchi Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice Endocrinology 148 2007 2690 2697 (Pubitemid 46984786)
53. E.A. Ashley The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Cardiovasc. Res. 65 2005 73 82 (Pubitemid 40038480)
54. M.F. Berry Apelin has in vivo inotropic effects on normal and failing hearts Circulation 110 2004 II187 II193
55. K. Kuba Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload Circ. Res. 101 2007 E32 E42
56. D.N. Charo Endogenous regulation of cardiovascular function by apelin-APJ Am. J. Physiol. Heart Circ. Physiol. 297 2009 H1904 H1913
57. P. Yue Apelin is necessary for the maintenance of insulin sensitivity Am. J. Physiol. Endocrinol. Metab. 298 2010 E59 E67
58. J.P. Goetze Apelin: a new plasma marker of cardiopulmonary disease Regul. Pept. 133 2006 134 138 (Pubitemid 41820346)
59. Ashley, E. et al. (2005) Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof patent. USP20050152836
60. I. Falcao-Pires Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension Am. J. Physiol. Heart Circ. Physiol. 296 2009 H2007 H2014
61. A.G. Japp Vascular effects of apelin in vivo in man J. Am. Coll. Cardiol. 52 2008 908 913
62. X. Cheng Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats Eur. J. Pharmacol. 470 2003 171 175 (Pubitemid 36694473)
63. K. Tatemoto The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism Regul. Pept. 99 2001 87 92 (Pubitemid 32522535)
64. Y.X. Jia Apelin activates l-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas Peptides 28 2007 2023 2029 (Pubitemid 47419100)
65. S.C. Sorli Apelin is a potent activator of tumour neoangiogenesis Oncogene 26 2007 7692 7699 (Pubitemid 350224216)
66. X.J. Zeng Apelin protects heart against ischemia/reperfusion injury in rat Peptides 30 2009 1144 1152
67. H. Kidoya Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia Blood 115 2010 3166 3174
68. P.P. Huang Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans Thromb. Haemost. 98 2007 1335 1342 (Pubitemid 350239107)
69. J.F. Caro Leptin: the tale of an obesity gene Diabetes 45 1996 1455 1462 (Pubitemid 26357535)
70. J. Licinio Sex differences in circulating human leptin pulse amplitude: clinical implications J. Clin. Endocrinol. Metab. 83 1998 4140 4147 (Pubitemid 28513608)
71. R.S. Ahima, and J.S. Flier Leptin Annu. Rev. Physiol. 62 2000 413 437 (Pubitemid 30618269)
72. M.G. Myers Mechanisms of leptin action and leptin resistance Annu. Rev. Physiol. 70 2008 537 556 (Pubitemid 351738191)
73. S. Loffreda Leptin regulates proinflammatory immune responses FASEB J. 12 1998 57 65 (Pubitemid 28060271)
74. I. Stelzer Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation Transl. Res. 159 2012 118 124
75. S.Q. Yang Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc. Natl. Acad. Sci. U. S. A. 94 1997 2557 2562 (Pubitemid 27136914)
76. G.M. Lord Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression Nature 394 1998 897 901 (Pubitemid 28410912)
77. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770 (Pubitemid 28485436)
78. J. Webber Energy balance in obesity Proc. Nutr. Soc. 62 2003 539 543 (Pubitemid 36841629)
79. N. Al-Daghri Role of leptin in glucose metabolism in type 2 diabetes Diabetes Obes. Metab. 4 2002 147 155 (Pubitemid 34567671)
80. R.V. Considine Serum immunoreactive-leptin concentrations in normal-weight and obese humans N. Engl. J. Med. 334 1996 292 295 (Pubitemid 26033933)
81. A.M. Lefebvre Depot-specific differences in adipose tissue gene expression in lean and obese subjects Diabetes 47 1998 98 103
82. K. El-Haschimi Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity J. Clin. Invest. 105 2000 1827 1832 (Pubitemid 30421764)
83. C. Bjorbak SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985 J. Biol. Chem. 275 2000 40649 40657
84. I.S. Farooqi Effects of recombinant leptin therapy in a child with congenital leptin deficiency N. Engl. J. Med. 341 1999 879 884 (Pubitemid 29427050)
85. C.T. Montague Congenital leptin deficiency is associated with severe early-onset obesity in humans Nature 387 1997 903 908 (Pubitemid 27289591)
86. E.A. Oral Leptin-replacement therapy for lipodystrophy N. Engl. J. Med. 346 2002 570 578 (Pubitemid 34438818)
87. C.S. Mantzoros, and J.S. Flier Editorial: leptin as a therapeutic agent - trials and tribulations J. Clin. Endocrinol. Metab. 85 2000 4000 4002 (Pubitemid 32055342)
88. M.A. Valentino Central and peripheral molecular targets for antiobesity pharmacotherapy Clin. Pharmacol. Ther. 87 2010 652 662
89. G. Fruhbeck Pivotal role of nitric oxide in the control of blood pressure after leptin administration Diabetes 48 1999 903 908 (Pubitemid 29153093)
90. G. Lembo Leptin induces direct vasodilation through distinct endothelial mechanisms Diabetes 49 2000 293 297 (Pubitemid 30071008)
91. A. Rodriguez The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats J. Hypertens. 24 2006 1589 1597 (Pubitemid 44162461)
92. M. Aizawa-Abe Pathophysiological role of leptin in obesity-related hypertension J. Clin. Invest. 105 2000 1243 1252 (Pubitemid 30266077)
93. A. Zeidan Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy J. Pharmacol. Exp. Ther. 315 2005 1075 1084 (Pubitemid 41635393)
94. M. Karmazyn Leptin as a cardiac hypertrophic factor: a potential target for therapeutics Trends Cardiovasc. Med. 17 2007 206 211 (Pubitemid 47089011)
95. K.R. McGaffin Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury Cardiovasc. Res. 77 2008 54 63 (Pubitemid 351195151)
96. R.H. Unger Hyperleptinemia: protecting the heart from lipid overload Hypertension 45 2005 1031 1034 (Pubitemid 40770299)
97. R. Cooper ACE, angiotensinogen and obesity: a potential pathway leading to hypertension J. Hum. Hypertens. 11 1997 107 111 (Pubitemid 27202252)
98. D.J. Campbell, and J.F. Habener Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ Endocrinology 121 1987 1616 1626 (Pubitemid 18012763)
99. C. Karlsson Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II J. Clin. Endocrinol. Metab. 83 1998 3925 3929 (Pubitemid 28513574)
100. F.M. Gregoire Understanding adipocyte differentiation Physiol. Rev. 78 1998 783 809 (Pubitemid 28340604)
101. S. Engeli Physiology and pathophysiology of the adipose tissue renin-angiotensin system Hypertension 35 2000 1270 1277 (Pubitemid 30413663)
102. S. Thatcher The adipose renin-angiotensin system: role in cardiovascular disease Mol. Cell. Endocrinol. 302 2009 111 117
103. R.C. Frederich Jr. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue Hypertension 19 1992 339 344
104. J. Aubert Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells Biochem. J. 328 Pt 2 1997 701 706 (Pubitemid 27515619)
105. I. Safonova Regulation by fatty acids of angiotensinogen gene expression in preadipose cells Biochem. J. 322 Pt 1 1997 235 239 (Pubitemid 27095546)
106. L.A. Cassis Location and regulation of rat angiotensinogen messenger RNA Hypertension 11 1988 591 596
107. J. Janke Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors Diabetes 51 2002 1699 1707 (Pubitemid 34564280)
108. P. Fuentes The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation J. Endocrinol. 206 2010 75 83
109. L. Yvan-Charvet, and A. Quignard-Boulange Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity Kidney Int. 79 2011 162 168
110. R.R. Townsend The effects of angiotensin-II on lipolysis in humans Metabolism 50 2001 468 472 (Pubitemid 32321958)
111. L. Yvan-Charvet Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue Endocrinology 150 2009 1421 1428
112. F. Massiera Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation FASEB J. 15 2001 2727 2729
113. S.H. Santos Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism Diabetes 57 2008 340 347
114. K. Gorzelniak Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension J. Hypertens. 20 2002 965 973 (Pubitemid 34913678)
115. S. Engeli Weight loss and the renin-angiotensin-aldosterone system Hypertension 45 2005 356 362 (Pubitemid 40315803)
116. C.M. Steppan The hormone resistin links obesity to diabetes Nature 409 2001 307 312 (Pubitemid 32151228)
117. K.M. Barnes, and J.L. Miner Role of resistin in insulin sensitivity in rodents and humans Curr. Protein Pept. Sci. 10 2009 96 107
118. F. Liu A paradox: insulin inhibits expression and secretion of resistin which induces insulin resistance World J. Gastroenterol. 14 2008 95 100 (Pubitemid 351314334)
119. C. Chen Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells Am. J. Physiol. Heart Circ. Physiol. 299 2010 H193 H201
120. L.K. Heilbronn Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects J. Clin. Endocrinol. Metab. 89 2004 1844 1848 (Pubitemid 38507943)
121. M. Degawa-Yamauchi Serum resistin (FIZZ3) protein is increased in obese humans J. Clin. Endocrinol. Metab. 88 2003 5452 5455 (Pubitemid 37452753)
122. J.M. Way Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists J. Biol. Chem. 276 2001 25651 25653
123. M.A. Lazar Resistin- and obesity-associated metabolic diseases Horm. Metab. Res. 39 2007 710 716 (Pubitemid 350099817)
124. I. Nagaev, and U. Smith Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle Biochem. Biophys. Res. Commun. 285 2001 561 564 (Pubitemid 32918109)
125. J. Janke Resistin gene expression in human adipocytes is not related to insulin resistance Obes. Res. 10 2002 1 5 (Pubitemid 135686624)
126. I.M. Jazet Adipose tissue as an endocrine organ: impact on insulin resistance Neth. J. Med. 61 2003 194 212 (Pubitemid 39089399)
127. L. Patel Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem. Biophys. Res. Commun. 300 2003 472 476 (Pubitemid 38375833)
128. M. Bajaj Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients Int. J. Obes. Relat. Metab. Disord. 28 2004 783 789 (Pubitemid 38746224)
129. R. Ohmori Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease J. Am. Coll. Cardiol. 46 2005 379 380 (Pubitemid 40966873)
130. M.P. Reilly Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 2005 932 939 (Pubitemid 40279897)
131. G.S. Hotamisligil Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91 (Pubitemid 23036092)
132. K. Clement Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects FASEB J. 18 2004 1657 1669 (Pubitemid 39463705)
133. K.T. Uysal Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function Nature 389 1997 610 614 (Pubitemid 27446179)
134. P. Lofgren Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue Diabetes 49 2000 688 692 (Pubitemid 30339981)
135. H. Semb Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo J. Biol. Chem. 262 1987 8390 8394 (Pubitemid 17104269)
136. S. Thalmann, and C.A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc. Res. 75 2007 690 701 (Pubitemid 47238732)
137. N. Maenhaut, and J. Van de Voorde Regulation of vascular tone by adipocytes BMC Med. 9 2011 25
138. S. Schenk Insulin sensitivity: modulation by nutrients and inflammation J. Clin. Invest. 118 2008 2992 3002
139. T. Mateo A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles Blood 110 2007 1895 1902 (Pubitemid 47443902)
140. H. Zhang Role of TNF-alpha in vascular dysfunction Clin. Sci. (Lond.) 116 2009 219 230
141. M. Bullo Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression Obes. Res. 11 2003 525 531 (Pubitemid 41202413)
142. J. Chudek, and A. Wiecek Adipose tissue, inflammation and endothelial dysfunction Pharmacol. Rep. 58 Suppl. 2006 81 88
143. J.N. Fain Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans Endocrinology 145 2004 2273 2282 (Pubitemid 38535056)
144. V. Rotter Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects J. Biol. Chem. 278 2003 45777 45784 (Pubitemid 37432722)
145. K. Nonogaki Interleukin-6 stimulates hepatic triglyceride secretion in rats Endocrinology 136 1995 2143 2149
146. P.M. Ridker Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 101 2000 1767 1772 (Pubitemid 30213096)
147. C. Langenberg Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers Diabetes Care 29 2006 1363 1369 (Pubitemid 44125936)
148. M. Klouche Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor J. Immunol. 163 1999 4583 4589 (Pubitemid 29474529)
149. J.N. Ihle Signaling through the hematopoietic cytokine receptors Annu. Rev. Immunol. 13 1995 369 398
150. V. Lamounier-Zepter Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease Circ. Res. 105 2009 326 334
151. M. Doi Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men Cardiovasc. Diabetol. 10 2011 44
152. H. Elmasri Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells FASEB J. 23 2009 3865 3873
153. M. Furuhashi Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Nature 447 2007 959 965 (Pubitemid 46975747)
154. H. Lan Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity J. Lipid Res. 52 2011 646 656
155. A. Asplund-Carlson Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men Diabetologia 36 1993 817 825 (Pubitemid 23248153)
156. A. Fukuhara Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 (Pubitemid 40139988)
157. J.K. Sethi, and A. Vidal-Puig Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol. Med. 11 2005 344 347 (Pubitemid 41080573)
158. S. Pilz Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions J. Endocrinol. Invest. 30 2007 138 144 (Pubitemid 46614445)
159. J.E. Brown Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells J. Mol. Endocrinol. 44 2010 171 178
160. J.R. Revollo Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab. 6 2007 363 375 (Pubitemid 350011996)
161. T.B. Dahl Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 115 2007 972 980 (Pubitemid 46328290)
162. S.Y. Lim The novel adipocytokine visfatin exerts direct cardioprotective effects J. Cell. Mol. Med. 12 2008 1395 1403